These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10940219)

  • 21. Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of beta-sheets in Alzheimer's beta-amyloid fibrils.
    Antzutkin ON; Balbach JJ; Leapman RD; Rizzo NW; Reed J; Tycko R
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13045-50. PubMed ID: 11069287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of chemical exchange between soluble and aggregated states of beta-amyloid by solution-state NMR upon variation of salt conditions.
    Narayanan S; Reif B
    Biochemistry; 2005 Feb; 44(5):1444-52. PubMed ID: 15683229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CLAC binds to aggregated Abeta and Abeta fragments, and attenuates fibril elongation.
    Kakuyama H; Söderberg L; Horigome K; Winblad B; Dahlqvist C; Näslund J; Tjernberg LO
    Biochemistry; 2005 Nov; 44(47):15602-9. PubMed ID: 16300410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review: modulating factors in amyloid-beta fibril formation.
    McLaurin J; Yang D; Yip CM; Fraser PE
    J Struct Biol; 2000 Jun; 130(2-3):259-70. PubMed ID: 10940230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
    Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hsp104 targets multiple intermediates on the amyloid pathway and suppresses the seeding capacity of Abeta fibrils and protofibrils.
    Arimon M; Grimminger V; Sanz F; Lashuel HA
    J Mol Biol; 2008 Dec; 384(5):1157-73. PubMed ID: 18851977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. alphaB-crystallin competes with Alzheimer's disease beta-amyloid peptide for peptide-peptide interactions and induces oxidation of Abeta-Met35.
    Narayanan S; Kamps B; Boelens WC; Reif B
    FEBS Lett; 2006 Oct; 580(25):5941-6. PubMed ID: 17046756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide.
    Cerf E; Sarroukh R; Tamamizu-Kato S; Breydo L; Derclaye S; Dufrêne YF; Narayanaswami V; Goormaghtigh E; Ruysschaert JM; Raussens V
    Biochem J; 2009 Jul; 421(3):415-23. PubMed ID: 19435461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular modeling of the core of Abeta amyloid fibrils.
    Guo JT; Wetzel R; Xu Y
    Proteins; 2004 Nov; 57(2):357-64. PubMed ID: 15340923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic analysis of beta-amyloid fibril elongation.
    Cannon MJ; Williams AD; Wetzel R; Myszka DG
    Anal Biochem; 2004 May; 328(1):67-75. PubMed ID: 15081909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collagenous Alzheimer amyloid plaque component assembles amyloid fibrils into protease resistant aggregates.
    Söderberg L; Dahlqvist C; Kakuyama H; Thyberg J; Ito A; Winblad B; Näslund J; Tjernberg LO
    FEBS J; 2005 May; 272(9):2231-6. PubMed ID: 15853808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of peptidyl compounds that affect beta-amyloid aggregation: importance of surface tension and context.
    Gibson TJ; Murphy RM
    Biochemistry; 2005 Jun; 44(24):8898-907. PubMed ID: 15952797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
    Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
    J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid membrane templates the ordering and induces the fibrillogenesis of Alzheimer's disease amyloid-beta peptide.
    Chi EY; Ege C; Winans A; Majewski J; Wu G; Kjaer K; Lee KY
    Proteins; 2008 Jul; 72(1):1-24. PubMed ID: 18186465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterizing bathocuproine self-association and subsequent binding to Alzheimer's disease amyloid beta-peptide by NMR.
    Yao S; Cherny RA; Bush AI; Masters CL; Barnham KJ
    J Pept Sci; 2004 Apr; 10(4):210-7. PubMed ID: 15119593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.
    Barghorn S; Nimmrich V; Striebinger A; Krantz C; Keller P; Janson B; Bahr M; Schmidt M; Bitner RS; Harlan J; Barlow E; Ebert U; Hillen H
    J Neurochem; 2005 Nov; 95(3):834-47. PubMed ID: 16135089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer beta-amyloid peptides: structures of amyloid fibrils and alternate aggregation products.
    Gorman PM; Chakrabartty A
    Biopolymers; 2001; 60(5):381-94. PubMed ID: 12115148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure and orientation of peptide inhibitors bound to beta-amyloid fibrils.
    Chen Z; Krause G; Reif B
    J Mol Biol; 2005 Dec; 354(4):760-76. PubMed ID: 16271725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Model of Alzheimer's disease amyloid-beta peptide based on a RNA binding protein.
    Mathura VS; Paris D; Ait-Ghezala G; Quadros A; Patel NS; Kolippakkam DN; Volmar CH; Mullan MJ
    Biochem Biophys Res Commun; 2005 Jul; 332(2):585-92. PubMed ID: 15896718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of trypsin to fibrillar amyloid beta-protein.
    Chander H; Chauhan A; Wegiel J; Malik M; Sheikh A; Chauhan V
    Brain Res; 2006 Apr; 1082(1):173-81. PubMed ID: 16510132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.